Dr. Mamlouk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-563-7100
Education & Training
Jordan University of Science and Technology FOMClass of 2009
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2019 - 2026
AL State Medical License 2024 - 2025
GA State Medical License 2024 - 2025
LA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
- Join now to see all
Publications & Presentations
PubMed
- Immune Checkpoint Inhibitor-Associated Nephrotoxicity.Omar Mamlouk, Farhad R Danesh
Nephron. 2024-01-01 - Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response.Vishnupriyadevi Parvathareddy, Umut Selamet, Aditi A Sen, Omar Mamlouk, Juhee Song
Cancers. 2023-10-27 - 3 citationsPathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor-Induced Kidney Injury.Ala Abudayyeh, Liye Suo, Heather Lin, Omar Mamlouk, Noha Abdel-Wahab
Cancers. 2022-10-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
